Imatinib Mesylate TabletsImatinib Mesylate tablets, known as STRITINIB 400mg and IMATIB 100mg, are pivotal in treating various cancers, notably chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). By inhibiting specific proteins like BCR-ABL and KIT, Imatinib blocks abnormal cell growth, slowing or halting cancer progression. Benefits include increased survival rates, tumor shrinkage, and improved symptoms. Common effects include reduced fatigue, improved appetite, and enhanced energy levels. However, side-effects like nausea, muscle cramps, and fluid retention may occur. Despite potential adverse reactions, Imatinib tablets represent a significant breakthrough in targeted cancer therapy, offering hope and efficacy for patients with CML and GIST.
|
|
MODERN TIMES HELP LINES PHARMA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |